Related by context. Frequent words. (Click for all words.) 71 Receives Orphan Drug Designation 70 FDA Accepts 69 Pirfenidone 69 R sorafenib tablets 68 Meets Primary Endpoint 67 Soliris TM eculizumab 67 Orphan Drug status 67 Panzem R 67 Daclizumab 67 Ambrisentan 67 Initiates Phase II 67 Kuvan R 67 refractory chronic lymphocytic 66 Ixempra 66 Drug Candidate 66 Phase III Clinical Trial 66 Presents Positive 66 Pivotal Phase III 65 Vilazodone 65 phase IIb clinical 65 Golimumab 65 Copegus R 65 Argatroban 65 KRN# 65 Prestara 65 pseudobulbar affect PBA 65 Completes Enrollment 65 Onalta 64 Alemtuzumab 64 Patient Enrollment 64 Ticagrelor 64 DDP# 64 ATL# [001] 64 Orphan Drug Status 64 Arimoclomol 64 Phase III Trial 64 Zoraxel 64 ThermoDox R 64 orphan designation 64 Aurexis 64 Junovan 64 Mipomersen 63 Entereg R 63 vosaroxin 63 CDP# 63 eprodisate KIACTA TM 63 Application MAA 63 orphan medicinal product 63 liposomal formulation 63 GLPG# 63 Eculizumab 63 Belimumab 63 Epratuzumab 63 Pivotal Trial 63 Icatibant 63 Fibrillex TM 63 Clofarabine 63 Plenaxis R 63 Cetrorelix 63 orBec 63 Microplasmin 63 metastatic castration resistant 63 Application BLA 63 ALN TTR 63 Proxinium TM 63 registrational trial 63 Urocidin 63 GEM #S 63 ZALBIN 63 Nexavar ® 63 Generic Version 63 Denufosol 63 faropenem 63 Genasense ® 63 multi kinase inhibitor 63 proteasome inhibitor 63 gets USFDA nod 63 NEBIDO R 62 Bicifadine 62 Positive Opinion 62 neovascular age 62 Fast Track Designation 62 FIRAZYR 62 Dendreon Provenge 62 Initiate Phase 62 Aliskiren 62 TELINTRA 62 phase IIa 62 IND Investigational New 62 Amrubicin 62 Orphan Drug designation 62 FDA Orphan Drug 62 Pulmonary Arterial Hypertension 62 phase IIa clinical 62 Epidermal Growth Factor Receptor 62 rilonacept 62 Phenoptin 62 Phase IIa clinical trials 62 metastatic castrate resistant 62 StromaCel Inc. 62 Pralatrexate